Influence of pharmaceutical funding on the conclusions of meta-analyses
- PMID: 18024481
- PMCID: PMC2128680
- DOI: 10.1136/bmj.39381.655845.BE
Influence of pharmaceutical funding on the conclusions of meta-analyses
Abstract
Original data are sound, but conclusions should be interpreted with caution
Conflict of interest statement
Competing interests: RAE has worked as a consultant to drug companies for many years over a wide range of issues involving liability, parallel importation, and Food and Drug Administration matters. He has not worked for a drug company on conflicts of interest questions of the sort discussed here. The Institute for Policy Information, which has ties to the drug industry, provided financial support for a book he recently wrote.
Comment on
-
Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study.BMJ. 2007 Dec 8;335(7631):1202-5. doi: 10.1136/bmj.39376.447211.BE. Epub 2007 Nov 16. BMJ. 2007. PMID: 18024482 Free PMC article. Review.
References
-
- Studdert DM, Mello MM, Brennan TA. Financial conflict of interest in physicians’ relationships with the pharmaceutical industry—self-regulation in the shadow of federal prosecution. N Engl J Med 2004;351:1891-900. - PubMed
-
- Kassirer JP. On the take: how medicine’s complicity with big business can endanger your health. New York: Oxford University Press, 2005
-
- Avorn J. Powerful medicines: the benefits, risks, and costs of prescription drugs. New York: Random House, 2004
-
- Campbell EG, Gruen RL, Mountford J, Miller LG, Clearly PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med 2007;356:1742-50. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources